Spyre Therapeutics Inc.
Biotechnology
Healthcare
SYRE
50.89 M shares
NASDAQ US
traded
09 Apr 2025
listed
no
open
11.44
52 week high
39.58
high
13.76
52 week low
11.80
low
10.91
growth
-61.75 %
previous Close
11.80
P/E ratio
-10
market cap
1.42 B
div yield
0
net incoming
-69.03 M
-77.74 %
net profit margin
-6902800000.00 %
0.00 %
operating incoming
-55.39 M
-25.47 %
net change in cash
26.44 M
114.49 %
cash on hand
71.58 M
58.56 %
top